Raymond Turnure, MD
Family Medicine · Rocklin, CANPI 1639157423
Payments from drug & device makers
Across 234 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$283
- Amgen$220
- GSK$213
- Biohaven Pharmaceuticals, Inc.$138
- Ipsen Biopharmaceuticals, Inc$124
- plus $1K from 24 others
What the payments were for
- Food & beverage$4,15497%
- Education$1363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 133 | $2,205 |
| Novo Nordisk | 13 | $283 |
| Amgen | 9 | $220 |
| GSK | 11 | $213 |
| Biohaven Pharmaceuticals, Inc. | 7 | $138 |
| Ipsen Biopharmaceuticals, Inc | 5 | $124 |
| Pfizer | 7 | $115 |
| Lilly USA, LLC | 6 | $106 |
| Astellas Pharma US Inc | 2 | $97 |
| Amarin Pharma, Inc. | 5 | $95 |
| Kaleo, Inc. | 5 | $92 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $88 |
| AstraZeneca | 4 | $62 |
| Merz Pharmaceuticals, LLC | 1 | $46 |
| Sanofi-aventis U.S. LLC | 2 | $41 |
| Sanofi Pasteur Inc. | 2 | $38 |
| Merz North America, Inc. | 1 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Eisai Inc. | 2 | $27 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Boston Scientific | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Exact Sciences | 1 | $17 |
| Si-bone, Inc. | 1 | $16 |
| Merck | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
How this compares
$4,290 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $1,351 |
| Levothyroxine Sodium | 47 | $566 |
| Trazodone Hcl | 43 | $455 |
| Tamsulosin Hcl | 32 | $403 |
| Losartan Potassium | 39 | $366 |
| Atorvastatin Calcium | 56 | $356 |
| Simvastatin | 27 | $321 |
| Lisinopril | 18 | $298 |
| Celecoxib | 11 | $262 |
| ValacyclovirValacyclovir Hcl | 12 | $239 |
| Alprazolam | 20 | $221 |
| Zolpidem Tartrate | 23 | $195 |
| Amlodipine Besylate | 23 | $172 |
| Montelukast Sodium | 15 | $164 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 11 | $138 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Rocklin
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.